Filing Flows › Macrogenics (MGNX) › Collaborative and other agreements revenue
Macrogenics (MGNX) Collaborative and other agreements revenue by quarter
Macrogenics' Collaborative and other agreements revenue was $25.5M in Q2 2026 (second quarter 2026), up 45-fold from Q1 2026. Over the last 4 quarters it ranged from $570K (Q1 2026) to $53.0M (Q3 2025).
| Quarter | Collaborative and other agreements revenue | Q/Q | Y/Y |
|---|---|---|---|
| Q2 2026 | $25.5M | 45× | — |
| Q1 2026 | $570K | -99% | -92% |
| Q3 2025 | $53.0M | +653% | — |
| Q1 2025 | $7.0M | — | — |
Q2 2026 at a glance
Macrogenics, Q2 2026: revenue $32.8M (+378% year over year), operating margin -42.2%, net earnings $19.5M, operating cash flow −$40.7M. The chart follows the revenue to costs, profit and cash.
Questions
What is Macrogenics' Collaborative and other agreements revenue?
Macrogenics' Collaborative and other agreements revenue was $25.5M in Q2 2026 (second quarter 2026), up 45-fold from Q1 2026.
How has Macrogenics' Collaborative and other agreements revenue changed?
Over the last 4 quarters it ranged from $570K (Q1 2026) to $53.0M (Q3 2025).